Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
, ( ) , [24]
you're getting a compound with the exact amino-acid sequencing, free from the contaminants and fillers that plague lower-quality sources
Imbruvica (ibrutinib) Disease area(s): Oncology/hematology Manufacturer(s): AbbVie/Johnson & Johnson 2024 Sales (USD): $6.39 billion Why it sold so well: In 2024, Johnson & Johnson saw a 7% decline in global revenues of Imbruvica, primarily due to decreased demand and lower market share in the US, as well as reduced collaboration revenues internationally
Immune function : Strengthens the bodys defenses by supporting cellular renewal
US$ 28.25
US$ 24.43
US$ 20.03
US$ 27.03
US$ 20.00
US$ 29.48
US$ 25.05
US$ 24.07
